Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
Clinical trial NCT06654297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06654297
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-27
- Primary completion
- 2025-06-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.